Boiarsky D, Tewari AK, Gulhan DC, Bakouny Z, et al. A panel-based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration-resistant prostate cancer. Prostate 2024 Sep 9. doi: 10.1002/pros.24788.
PMID: 39252459